Despite the provocative claim circulating online, no court or regulatory body has confirmed that GOLO’s diet program testimonials were fabricated by paid actors. The allegation stems largely from consumer skepticism on review platforms like Trustpilot and Yelp, where some users have flagged suspiciously uniform five-star reviews. But the actual class action lawsuit filed against GOLO — Bubak v. GOLO, LLC — focused on misleading health and efficacy claims, not on the use of paid actors. That case was dismissed in GOLO’s favor in January 2024, and an appeal to the Ninth Circuit in 2025 largely upheld the dismissal.
That said, the consumer frustration driving these allegations is real and worth examining. GOLO has faced pointed questions about the authenticity of its marketing, even as the company maintains that all testimonials come from real customers or trial members who have maintained their weight loss for over a year. On Yelp, roughly 20 out of 25 reviews gave one star, with some five-star reviews flagged as potentially inauthentic by the platform’s own filters. Whether or not actors were involved, the gap between GOLO’s marketing and many consumers’ actual experiences has fueled legitimate distrust.
Table of Contents
- Was a Class Action Filed Claiming GOLO Diet Testimonials Were Fabricated by Paid Actors?
- Why the GOLO Lawsuit Was Dismissed and What the Ninth Circuit Ruled
- What GOLO Says About Its Testimonials and Marketing Practices
- How Consumers Can Evaluate Supplement Testimonials and Protect Themselves
- Why Federal Preemption Makes Supplement Advertising Lawsuits Difficult
- The Role of Online Reviews in Shaping Perceptions of GOLO
- What Comes Next for GOLO and Supplement Industry Accountability
- Frequently Asked Questions
Was a Class Action Filed Claiming GOLO Diet Testimonials Were Fabricated by Paid Actors?
Not exactly. The primary class action against GOLO — filed in 2021 by Vincenzza Bubak of Valley Springs, California — alleged “false and misleading labeling and advertising,” but its specific claims centered on health and efficacy misrepresentations, not fabricated testimonials. Bubak, who purchased GOLO’s Release supplement in December 2020, argued the company made implied disease claims by linking insulin resistance to conditions like heart disease and Alzheimer’s. The lawsuit also challenged GOLO’s “clinically proven” marketing language, alleging the studies cited did not meet the standard of proper double-blind, peer-reviewed research. The case was filed in the U.S. District Court for the Eastern District of California under Case No.
1:21-cv-00492. It brought claims under California’s Unfair Competition Law, False Advertising Law, and Consumer Legal Remedies Act, as well as allegations of misbranding under the Federal Food, Drug, and Cosmetic Act. The “paid actors” narrative appears to have emerged separately from consumer complaints on social media and review platforms rather than from the formal legal complaint itself. This is an important distinction — what circulates online as the basis for a lawsuit and what actually appears in the court filing can be very different things. For consumers who saw headlines about GOLO and paid actors, the takeaway is that the legal system addressed a narrower set of claims than the internet conversation might suggest. The broader skepticism about testimonials, while understandable, has not been tested or validated in court.
Why the GOLO Lawsuit Was Dismissed and What the Ninth Circuit Ruled
On January 8, 2024, Judge Dale A. Drozd dismissed the Bubak class action, entering judgment in GOLO’s favor. The dismissal was not based on whether GOLO’s advertising was truthful or misleading in a general sense. Instead, the court found that Bubak’s state-law claims — under California’s UCL, FAL, and CLRA — were preempted by federal law, specifically the Federal Food, Drug, and Cosmetic Act. In plain terms, the judge ruled that because federal law already governs supplement labeling and marketing claims, state-level consumer protection lawsuits could not be used to impose additional or different requirements. Bubak appealed to the U.S. Court of Appeals for the Ninth Circuit, where the case was docketed as No.
24-492. On October 9, 2025, the Ninth Circuit issued a memorandum opinion that largely upheld the lower court’s reasoning, finding that federal law barred the private suit. This outcome was a significant win for GOLO’s legal team at Sidley Austin, which highlighted the dismissal as a precedent for supplement companies facing state-law advertising challenges. However, it is critical to understand what this dismissal does not mean. A case being dismissed on preemption grounds is not a finding that the company’s advertising was truthful. It means the plaintiff brought claims under the wrong legal framework. If the FTC or FDA were to investigate GOLO’s marketing practices directly under federal authority, the preemption defense would not apply. As of now, no federal agency has filed an enforcement action against GOLO, but the door remains open for regulatory scrutiny outside of private lawsuits.
What GOLO Says About Its Testimonials and Marketing Practices
GOLO has been proactive in defending the authenticity of its marketing. The company officially states that all testimonials featured on its website and in television commercials come from real customers or trial members, not paid actors. According to GOLO’s published success stories, each featured individual has maintained their weight loss for over a year before being highlighted. The company frames its testimonial process as rigorous, positioning itself as a brand that stands behind its customer results. Interestingly, GOLO has also gone on the offensive against what it considers fraudulent attacks on its reputation.
The company has filed its own lawsuits against fake review sites and marketers who were selling fabricated negative reviews about GOLO products. This creates an unusual dynamic — the same company accused by some consumers of using fake positive testimonials has simultaneously fought against fake negative reviews. It suggests that the supplement marketplace is plagued by manufactured opinions on all sides, making it genuinely difficult for consumers to know what is authentic. For consumers trying to evaluate GOLO’s claims, the company’s official position is clear but not independently verifiable without access to internal records. The FTC’s Endorsement Guides require that testimonials reflect honest opinions and that material connections between endorsers and companies be disclosed. Whether GOLO’s practices fully comply with these guidelines has not been formally adjudicated.
How Consumers Can Evaluate Supplement Testimonials and Protect Themselves
The GOLO situation highlights a broader challenge in the supplement industry: testimonials are among the most powerful marketing tools available, and the line between genuine customer stories and curated, compensated endorsements is often blurry. Under FTC guidelines, companies must disclose material connections with endorsers — meaning if someone was paid, given free product, or otherwise compensated, that relationship must be clearly stated. But enforcement is inconsistent, and many companies operate in a gray area. When evaluating testimonials for any supplement, consumers should compare the marketing claims against the available clinical evidence. GOLO’s lawsuit centered partly on the gap between its “clinically proven” language and the actual quality of its studies.
A useful standard is to ask whether the studies cited are published in peer-reviewed journals, whether they used proper controls like double-blind methodology, and whether the sample sizes were large enough to be meaningful. If a company references “clinical studies” without providing direct links to published papers, that is a red flag worth noting. There is also a tradeoff between relying on review platforms and trusting company-curated testimonials. Platforms like Trustpilot and Yelp provide unfiltered consumer opinions, but they are also susceptible to manipulation in both directions — companies can solicit positive reviews, and competitors or disgruntled individuals can flood platforms with fabricated negative ones. The most reliable approach is to triangulate: check multiple review sources, look for detailed reviews that describe specific experiences rather than generic praise or condemnation, and weigh the overall pattern rather than individual outliers.
Why Federal Preemption Makes Supplement Advertising Lawsuits Difficult
The Bubak v. GOLO dismissal exposes a significant limitation for consumers who want to challenge supplement marketing through the courts. Federal preemption — the legal doctrine that federal law takes priority over conflicting state laws — has become an increasingly effective shield for supplement companies. When a court finds that the FDCA already governs the labeling and advertising claims at issue, state consumer protection statutes cannot be used to create additional requirements or penalties. This creates a frustrating gap.
The FDA and FTC have the authority to enforce federal standards against supplement companies, but they have limited resources and must prioritize among thousands of products on the market. Private lawsuits under state law have historically served as a supplementary enforcement mechanism, allowing consumers to hold companies accountable when federal agencies cannot or do not act. When preemption blocks those private suits, consumers are left waiting for federal agencies to take action — which may never come for any individual company. The warning for consumers considering legal action against supplement companies is that the path through state courts has become considerably narrower after rulings like the one in the GOLO case. Filing under state consumer protection laws without first evaluating preemption risk can result in years of litigation with no recovery. Consumers who believe a supplement company has engaged in deceptive practices may be better served by filing complaints directly with the FTC or their state attorney general’s office, which can investigate without the same preemption barriers that private plaintiffs face.
The Role of Online Reviews in Shaping Perceptions of GOLO
The consumer backlash against GOLO on platforms like Yelp — where approximately 20 out of 25 reviews were one-star ratings — tells a story that the courtroom did not fully address. Even when five-star reviews appeared, some were flagged by other users as suspiciously generic, using uniform language that read more like marketing copy than genuine personal accounts. This pattern is not unique to GOLO; it is common across the supplement industry, where companies frequently encourage satisfied customers to leave reviews while dissatisfied customers are often more motivated to post without prompting.
What makes the GOLO situation notable is the intensity of the disconnect. The company’s own marketing features enthusiastic, detailed success stories, while independent review platforms tell a starkly different story for many consumers. This gap does not prove fabrication, but it does suggest that the curated testimonials may not be representative of the average customer experience — a subtler form of misleading marketing that is difficult to challenge legally but easy for consumers to recognize.
What Comes Next for GOLO and Supplement Industry Accountability
With the Ninth Circuit’s 2025 ruling largely closing the door on the Bubak lawsuit, GOLO appears to have weathered its most significant legal challenge to date. No settlement has been reached in any GOLO consumer lawsuit, and no FTC enforcement action has been filed against the company. For now, GOLO continues to operate and market its Release Supplement and metabolic plan without court-imposed restrictions on its advertising practices.
Looking ahead, the supplement industry as a whole faces growing regulatory attention. The FTC has signaled increased scrutiny of health-related testimonials and endorsements, particularly in the weight loss space. If the agency turns its attention to GOLO or similar companies, the preemption defense that worked in private litigation would not apply. Consumers who have purchased GOLO products and feel misled should document their purchases and experiences, file complaints with the FTC at ReportFraud.ftc.gov, and monitor developments — because the legal landscape for supplement accountability is still shifting.
Frequently Asked Questions
Is there a GOLO class action settlement I can file a claim for?
No. As of the latest available information, no settlement has been reached in any GOLO consumer lawsuit. The primary case, Bubak v. GOLO, LLC, was dismissed in GOLO’s favor and the dismissal was upheld on appeal.
Did a court find that GOLO used paid actors in its testimonials?
No. No court or regulatory body has confirmed that GOLO used paid actors or fabricated testimonials. The lawsuit focused on misleading health and efficacy claims, not on the authenticity of testimonials. The paid actors allegation comes from consumer speculation on review platforms.
What was the GOLO lawsuit actually about?
The Bubak v. GOLO lawsuit alleged false and misleading labeling and advertising, including implied disease claims linking insulin resistance to serious health conditions, misleading “clinically proven” language, and misbranding under federal law. It was filed in 2021 in the Eastern District of California.
Why was the GOLO lawsuit dismissed?
The court found that the plaintiff’s state-law claims under California consumer protection statutes were preempted by the Federal Food, Drug, and Cosmetic Act. This means federal law was found to already cover the issues raised, blocking the state-level lawsuit.
Can I still take action if I feel misled by GOLO’s marketing?
Yes. You can file a complaint with the FTC at ReportFraud.ftc.gov or contact your state attorney general’s office. These agencies can investigate under federal authority without the preemption barriers that blocked the private lawsuit.
Has the FTC taken any action against GOLO?
No FTC enforcement action has been filed specifically against GOLO as of the latest available information. However, the FTC continues to scrutinize weight loss advertising across the supplement industry.